Revenio Group Oyj (REG1V) Stock Overview
Provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
No risks detected for REG1V from our risk checks.
REG1V Community Fair Values
Create NarrativeSee what 13 others think this stock is worth. Follow their fair value or set your own to get alerts.
Revenio Group Oyj Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €23.65 |
| 52 Week High | €35.84 |
| 52 Week Low | €21.35 |
| Beta | 1.43 |
| 1 Month Change | 1.07% |
| 3 Month Change | -14.16% |
| 1 Year Change | -31.45% |
| 3 Year Change | -36.39% |
| 5 Year Change | -39.36% |
| Change since IPO | 1,144.77% |
Recent News & Updates
Revenio Group Oyj's (HEL:REG1V) 25% Jump Shows Its Popularity With Investors
May 14
Earnings Miss: Revenio Group Oyj Missed EPS By 5.8% And Analysts Are Revising Their Forecasts
May 02Recent updates
Revenio Group Oyj's (HEL:REG1V) 25% Jump Shows Its Popularity With Investors
May 14Earnings Miss: Revenio Group Oyj Missed EPS By 5.8% And Analysts Are Revising Their Forecasts
May 02Is Revenio Group Oyj (HEL:REG1V) A Risky Investment?
Apr 23Here's What Analysts Are Forecasting For Revenio Group Oyj (HEL:REG1V) After Its Annual Results
Feb 16What Does Revenio Group Oyj's (HEL:REG1V) Share Price Indicate?
Jan 21
New Medical Devices And AI Integration Will Fuel Future Success In Medical Markets
Expansion into the Chinese market and successful product launches are set to drive significant future revenue growth across diverse markets.Shareholders Should Be Pleased With Revenio Group Oyj's (HEL:REG1V) Price
Oct 12Investors Shouldn't Overlook Revenio Group Oyj's (HEL:REG1V) Impressive Returns On Capital
Aug 11Calculating The Intrinsic Value Of Revenio Group Oyj (HEL:REG1V)
Jun 20What Does Revenio Group Oyj's (HEL:REG1V) Share Price Indicate?
May 21Revenio Group Oyj Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Apr 27It's Unlikely That The CEO Of Revenio Group Oyj (HEL:REG1V) Will See A Huge Pay Rise This Year
Mar 29€27.88 - That's What Analysts Think Revenio Group Oyj (HEL:REG1V) Is Worth After These Results
Feb 18Is Revenio Group Oyj (HEL:REG1V) Using Too Much Debt?
Feb 16Why Revenio Group Oyj (HEL:REG1V) Could Be Worth Watching
Dec 15Revenio Group Oyj (HEL:REG1V) Seems To Use Debt Rather Sparingly
Aug 03Is Revenio Group Oyj (HEL:REG1V) Potentially Undervalued?
Jun 13If EPS Growth Is Important To You, Revenio Group Oyj (HEL:REG1V) Presents An Opportunity
May 09Revenio Group Oyj (HEL:REG1V) Has A Rock Solid Balance Sheet
Apr 11A Look At The Fair Value Of Revenio Group Oyj (HEL:REG1V)
Mar 30If EPS Growth Is Important To You, Revenio Group Oyj (HEL:REG1V) Presents An Opportunity
Feb 08Why Revenio Group Oyj (HEL:REG1V) Could Be Worth Watching
Jan 26Revenio Group Oyj (HEL:REG1V) Has A Rock Solid Balance Sheet
Jan 06Is Revenio Group Oyj (HEL:REG1V) Worth €39.4 Based On Its Intrinsic Value?
Dec 09Is Revenio Group Oyj (HEL:REG1V) Using Too Much Debt?
Oct 06Is Revenio Group Oyj (HEL:REG1V) Potentially Undervalued?
Sep 17A Look At The Fair Value Of Revenio Group Oyj (HEL:REG1V)
Aug 20Does Revenio Group Oyj (HEL:REG1V) Have A Healthy Balance Sheet?
Jun 14Why Revenio Group Oyj (HEL:REG1V) Could Be Worth Watching
Jun 01A Look At The Intrinsic Value Of Revenio Group Oyj (HEL:REG1V)
May 18Here's Why I Think Revenio Group Oyj (HEL:REG1V) Is An Interesting Stock
Mar 27Revenio Group Oyj (HEL:REG1V) Has A Rock Solid Balance Sheet
Mar 14Calculating The Fair Value Of Revenio Group Oyj (HEL:REG1V)
Feb 16Should You Think About Buying Revenio Group Oyj (HEL:REG1V) Now?
Feb 03Shareholder Returns
| REG1V | FI Medical Equipment | FI Market | |
|---|---|---|---|
| 7D | 3.3% | 3.8% | 0.6% |
| 1Y | -31.4% | -20.5% | 7.7% |
Return vs Industry: REG1V underperformed the Finnish Medical Equipment industry which returned -21.9% over the past year.
Return vs Market: REG1V underperformed the Finnish Market which returned 7.7% over the past year.
Price Volatility
| REG1V volatility | |
|---|---|
| REG1V Average Weekly Movement | 3.4% |
| Medical Equipment Industry Average Movement | 5.0% |
| Market Average Movement | 4.1% |
| 10% most volatile stocks in FI Market | 7.2% |
| 10% least volatile stocks in FI Market | 2.5% |
Stable Share Price: REG1V has not had significant price volatility in the past 3 months compared to the Finnish market.
Volatility Over Time: REG1V's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 251 | Jouni Toijala | www.reveniogroup.fi |
Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally. The company offers iCare IC100, ST500, and IC200 tonometers; iCare HOME2, a tonometer to measure eye pressure; iCare Probes that are accessories of iCare tonometer for measuring intraocular pressure (IOP); iCare TONOVET Pro, a tonometer designed for use in surgical or emergency settings; and iCare TONOVET Plus tonometer, which is used for measuring IOP on animal patients by general veterinary practitioners, veterinary ophthalmologists and other veterinary medical personnel. It also provides imaging devices comprising iCare EIDON, a device with confocal retinal imaging; iCare DRSplus, a device for pupil imaging; and iCare COMPASS, which provides fundus perimetry with true-color confocal retinal images.
Revenio Group Oyj Fundamentals Summary
| REG1V fundamental statistics | |
|---|---|
| Market cap | €629.16m |
| Earnings (TTM) | €18.10m |
| Revenue (TTM) | €107.22m |
Is REG1V overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| REG1V income statement (TTM) | |
|---|---|
| Revenue | €107.22m |
| Cost of Revenue | €30.68m |
| Gross Profit | €76.54m |
| Other Expenses | €58.45m |
| Earnings | €18.10m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
Oct 30, 2025
| Earnings per share (EPS) | 0.68 |
| Gross Margin | 71.39% |
| Net Profit Margin | 16.88% |
| Debt/Equity Ratio | 8.8% |
How did REG1V perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/06 05:59 |
| End of Day Share Price | 2025/10/03 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Revenio Group Oyj is covered by 9 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Pia Rosqvist-Heinsalmi | Carnegie Investment Bank AB |
| Daniel Lepisto | Danske Bank |
| Pia Rosqvist-Heinsalmi | DNB Carnegie |